Clinical Trial Update: Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens

View source ↗

Summary

This is a completed observational study of antiretroviral-treated HIV patients who switch to regimens containing nevirapine plus two NRTIs. The update summarize…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Status: COMPLETED